Jones Nicole S sold $749K of CI

Jones Nicole S (See Remarks) sold 2,677 shares of Cigna Group (CI) at $279.61 ($0.75M total) on 2026-08-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Jones Nicole S
Published Aug 20, 2026, 9:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CI
Neutral
high confidence
Mentioned
$CI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CINeutralLow
01

Why it matters

The transaction is a routine insider sale under a pre‑arranged plan, with limited market impact.

02

Market read

Minor insider sale; unlikely to affect Cigna's stock price or sector sentiment.

03

What to watch

Potential future insider sales if the 10b5‑1 plan continues.

Relevance 4/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions; required for transparency.

Company-level read

Ticker impact

$CINeutralHigh confidence
Context

Officer Nicole Jones sold 2,677 Cigna shares for $748.5K via a 10b5‑1 plan.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale size (~$0.75M) is small relative to Cigna's market cap; insider sales of this magnitude rarely trigger price moves.

Market effects

None; health insurance sector unchanged.

None; U.S. market only.

None

Counterpoint

The sale could signal insider concern, but size is too small to be material.

Key entities

  • Cigna Group

    U.S. health services insurer (ticker CI).

  • Nicole Jones

    Cigna officer reporting the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UNHMed

UnitedHealth and other insurance stocks drag down the Dow after CMS proposes new anti-fraud rule

UnitedHealth (UNH), Humana (HUM), Cigna (CI), and CVS Health (CVS) stocks fell 8%, 8%, 2%, and 3% respectively, dragging down the Dow after CMS proposed a new anti-fraud rule. The rule, called CRUSH, aims to increase audits and recover improper payments, potentially saving $90B over 10 years. Oppenheimer analysts expect legal challenges and note savings may not be broad.

$UNHHighAI 8/10

Positive Medicaid signals, open enrollment trends: Recapping major payers' Q3 results

UnitedHealth Group reported Q3 profit of $4.1B (up from $2.3B YoY) and revenue of $112.7B. CVS Health earned $2.2B (up from a $4B loss YoY) on $108.4B revenue, announcing a split of its pharmacy business. Cigna and Elevance Health each posted $1.4B profit. Centene reduced losses to $71M (from $6.6B YoY) on $50.6B revenue. Humana saw $162M profit (down from $195M) on $41.15B revenue, with positive Medicare enrollment trends.